Your Source for Venture Capital and Private Equity Financings

A-Alpha Bio Snares $20M Series A Funding

2021-09-08
SEATTLE, WA, A-Alpha Bio, a biotechnology company, announced a $20M Series A funding led by Madrona Venture Group.
A-Alpha Bio, a biotechnology company, announced a $20M Series A funding led by Madrona Venture Group. Other participants include Perceptive Advisors' Perceptive Xontogeny Venture Fund (PXV Fund) and Lux Capital.

A-Alpha Bio leverages synthetic biology to quantitatively measure millions of protein-protein interactions and machine learning to generate high-resolution models of protein binding and interaction networks.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors